Basic Information
Basic information for LINC00662-268-13aa-2
Peptide Name LINC00662-268-13aa-2
Genome Position chr19:27728032-27728070[-]
Species Human
Peptide Sequence MPIVINQISRDAN
Peptide Length 13
Unique No (LINC00662-224-13aa,LINC00662-230-13aa,LINC00662-245-13aa-2,LINC00662-257-13aa-2,LINC00662-262-13aa,LINC00662-267-13aa)
Grand Average of Hydropathicity 0.0385
Relative Molecular Mass 1686.87
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000668513;LINC00662-268
Transcript Length 3064
Coding Ability 0.3133
DNA Sequence Corresponding to Peptide ATGCCTATAGTGATTAACCAAATATCACGTGATGCAAAC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :